Recurrence prevention in patients with urinary tract stone disease

Scientific World Journal

Volumn 4, Issue , 2004, Pages 35-41

  Tiselius, Hans Göran ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Calcium oxalate; Calcium phosphate; Cystine; Diet; Infection stone; Medical treatment; Recurrence prevention; Residual fragments; Uric acid

Indexed keywords

CLASSIFICATION; DIET; DRINKING; HUMAN; RECURRENT DISEASE; REVIEW; UROLITHIASIS;

DIET; DRINKING; HUMANS; RECURRENCE; URINARY CALCULI;

EID: 1442327141     PISSN: 23566140     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2004.3     Document Type: Review

References (42)

1. Ljunghall, S. (1977) Renal stone disease: studies of epidemiology and calcium metabolism. Scand. J. Urol. Nephrol. 41, 6-38.
2. Pak, C.Y.C., Resnick, M.I., and Preminger, G.M. (1997) Ethnic and geographic diversity of stone disease. Urology 50, 504-507.
3. Tiselius, H.G. (2000) Stone incidence and prevention. Braz. J. Urol. 26, 452-462.
4. Strohmaier, W.L. (2000) Course of calcium stone disease without treatment: what can we expect? Eur. Urol. 37, 339-344.
5. Tiselius, H.G. (2003) Epidemiology and medical management of stone disease. BJU Int. 91, 758-767.
6. Tiselius, H.G., Ackermann, D., Alken, P., Buck, C., Conort, P., and Callucci, M. (2001) Guidelines on urolithiasis. Eur. Urol. 40, 362-371.
7. Tiselius, H.G. (2001) Advisory Board of European Urolithiasis Research and Health Care Office Working Party of Lithiasis. Possibilities for preventing recurrent calcium stone formation: principles for the metabolic evaluation of patients with calcium stone disease. BJU Int. 88, 158-168.
8. Borghi, L., Meschi, T., Schianchi, T., Allegri, F., Guerra, A., Maggiore, U., and Novarini, A. (2002) Medical treatment of nephrolithiasis. Endocrin. Metab. Clin. N. Am. 31, 1051-1064.
9. Herring, L.C. (1962) Observations on the analysis of ten thousand urinary calculi. J. Urol. 88, 545-562.
10. Leusmann, D.B., Niggemann, H., Roth, S., and von Ahlen, H. (1995) Recurrence rates and severity of urinary calculi. Scand. J. Urol. Nephrol. 29, 279-283.
11. Brien, G., Schubert, G., and Bick, C. (1982) 10,000 Analyses of urinary calculi using x-ray diffraction and polarizing microscopy. Eur. Urol. 8, 251-256.
12. Hesse, A., Tiselius, H.G., and Jahnen, A. (2002) Urinary Stones. Diagnosis, Treatment and Prevention of Recurrence. S. Karger, Basel.
13. Rodman, J.S., Williams, J.J., and Peterson, C.M. (1984) Dissolution of uric acid calculi. J. Urol. 131, 1039-1044.
14. Polykoff, G.I. and Dretler, S.P. (1993) Ammonium urate calculi: review of 26 cases. J. Stone Dis. 5, 208-212.
15. Soble, J., Hamilton, B.D., and Streem, S.B. (1999) Ammonium acid urate calculi: a re-evaluation of risk factors. J. Urol. 161, 869-873.
16. Jacobs, D., Heimbach, D., and Hesse, A. (2001) Chemolysis of struvite stones by acidification of artifical urine. Scand. J. Urol. Nephrol. 35, 345-349.
17. Wall, I., Hellgren, E., Larsson, L., and Tiselius, H.G. (1986) Biochemical risk factors in patients with renal staghorn stone disease. Urology 28, 277-380.
18. Barbey, F., Joly, D., Rieu, P., Méjean, A., Daudon, M., and Jungers, P. (2000) Medical treatment of cystinuria: critical reappraisal of long-term results. J. Urol. 163, 1419-1423.
19. Tiselius, H.G. (1996) Solution chemistry of supersaturation. In Kidney Stones: Medical and Surgical Management. Coe, F.L., Favus, M.J., Pak, C.Y.C., Parks, J.H., and Preminger, G.M., Eds. Lippincott-Raven, Philadelphia. pp. 36-64.
20. Broadus, A.E. (1989) Primary hyperparathyrodism. J. Urol. 141, 723-728.
21. Mollerup, C.L., Bollerslev, J., and Blichert-Toft, M. (1994) Primary hyperparathyroidism: incidence and clinical and biochemical characteristics. Eur. J. Surg. 160, 485-489.
22. Rose, G.A. (1990) Primary hyperparathyroidism. In Renal Tract Stone. Wickham, J.E.A. and Buck, A.C., Eds. Churchill Livingstone, London. pp. 401-413.
23. Tiselus, H.G. (1999) Factors influencing the course of calcium oxalate stone disease. Eur. Urol. 36, 363-370.
24. Trinchiery, A., Ostini, F., Nespoli, R., Rovera, F., Montanari, E., and Zanetti, G. (1999) A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J. Urol. 162, 27-30.
25. Hess, B., Mauron, H., Ackermann, D., and Jaeger, Ph. (1999) Effects of a common sense diet on urinary composition and supersaturation in patients with idiopathic calcium urolithiasis. Eur. Urol. 36, 136-143.
26. Robertson, W.G. and Peacock, M. (1982) The pattern of urinary stone disease in Leeds and in the United Kingdom in relation to animal protein intake during the period 1960-1980. Urol. Int. 37, 394-399.
27. Preminger, G.M., Harvey, J.A., and Pak, C.Y.C. (1986) Comparative efficacy of "specific" potassium citrate therapy versus conservative management in nephrolithiasis of mild to moderate severity. J. Urol. 134, 658-661.
28. Pak, C.Y.C., Peters, P., Hurt, G., Kadesky, M., Fine, M., Reisman, D., Splann, F., Carmela, C., Freeman, A., Britton, F., Sakhaee, K., and Breslau, N.A. (1981) Is selective therapy of recurrent nephrolithiasis possible? Am. J. Med. 71, 615-622.
29. th International Symposium on Urolithiasis, Cape Town. Rogers, A.L., Hibbert, B.E., Hess, B., Khan, S.R., and Preminger, G.M., Eds. University of Cape Town, Rondebosch. pp. 349-355.
30. Yendt, E.R. and Cohanim, M. (1978) Prevention of calcium stones with thiazides. Kidney Int. 13, 397-409.
31. Backman, U., Danielson, B.G., Johansson, G., Ljunghall, S., and Wikström, B. (1979) Effects of therapy with bendroflumenthiazide in patients with recurrent renal calcium stones. Br. J. Urol. 51, 175-180.
32. Ohkawa, M., Tokunaga, S., Nakashima, T., Orito, M., and Hisazumi, H. (1992) Thiazide treatment of calcium urolithiasis in patients with idiopathic hypercalciuria. Br. J. Urol. 69, 571-576.
33. Ahlstrand, C., Tiselius, H.G., Larsson, L., and Hellgren, E. (1984) Clinical experience with long-term bendroflumethiazide treatment in calcium oxalate stone formers. Br. J. Urol. 56, 255-262.
34. Elomaa, I., Ala-Opas, M., and Porkka, L. (1984) Five years of experience with selective therapy in recurrent calcium stone nephrolithiasis. J. Urol. 132, 656-661.
35. Ahlstrand, C., Sandvall, K., and Tiselius, H.G. (1996) Prophylactic treatment of calcium-stone-formers with hydrochlorothiazide and magnesium. In Renal Stones-Aspects on Their Formation, Removal and Prevention. Tiselius, H.G., Ed. Akademitryck AB, Edsbruk, Sweden. pp. 195-197.
36. Heyburn, P.J., Robertson, W.G., and Peacock, M. (1982) Phosphate treatment of recurrent calcium stone disease. Nephron 32, 314-319.
37. Ettinger, B. (1976) Recurrent nephrolithiasis: natural history and effect of phosphate therapy. A double-blind controlled study. Am. J. Med. 61, 200-205.
38. Ettinger, B., Pak, C.Y.C., Citron, J.T., Thomas, C., Adams-Huet, B., and Vangessel, A. (1997) Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J. Urol. 158, 2069-2073.
39. Lee, Y.H., Huang, W.C., Tsai, J.Y., and Huang, J.K. (1999) The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm followup study. J. Urol. 161, 1453-1457.
40. Coe, F.L. and Kavalach, A.G. (1974) Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N. Engl. J. Med. 291, 1344-1350.
41. Ettinger, B., Tang, A., Citron, J.T., Livermore, B., and Williams, T. (1986) Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N. Engl. J. Med. 315, 1386-1389.
42. Tiselius, H.G., Berg, C., Fornander, A.-M., and Nilsson, M.-A. (1993) Effects of citrate on the different phases of calcium oxalate crystallization. Scanning Microsc. 7, 381-391.